Moreover, the latest studies have revealed that CDK4/6 inhibitors may stimulate the immune system, namely, CD8 T-cell immune memory cells, interact with the tumor microenvironment, and have antitumor immunity effects [15, 43]. The gene discussed is CDK4; the disease is neoplasm.